Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Mahmud

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|May 16, 2006
Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myelomaS Saraf, Y-H Chen, L C Dobogai, et al.
Data in Brief|April 8, 2020
Differentiation of ripe and unripe fruit flour using mineral composition data-Statistical assessmentAbbas F M Alkarkhi, Wasin A A Alqaraghuli, N R Mohamed Zam, et al.
Blood|March 1, 1996
Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-betaK Ohishi, N Katayama, R Itoh, et al.
Blood|June 22, 2001
Highly abundant genes in the transcriptosome of human and baboon CD34 antigen-positive bone marrow cellsI Gomes, T T Sharma, N Mahmud, et al.
Leukemia & Lymphoma|March 14, 1998
Role for C-MPL and its ligand thrombopoietin in early hematopoiesisN Katayama, R Itoh, T Kato, et al.
Alimentary Pharmacology & Therapeutics|August 10, 2000
Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel diseaseY S Ang, N Mahmud, B White, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2001
A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia--are central serotoninergic responses enhanced?T G Dinan, N Mahmud, O Rathore, et al.
Leukemia & Lymphoma|May 9, 2001
Bcl-2 in cell-cycle regulation of hematopoietic cells by transforming growth factor-beta1N Katayama, N Mahmud, K Nishii, et al.
Bone Marrow Transplantation|February 12, 2008
Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?S Chunduri, L C Dobogai, D Peace, et al.
Gastroenterology|January 29, 2000
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapyR J Farrell, A Murphy, A Long, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|May 16, 2006
Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myelomaS Saraf, Y-H Chen, L C Dobogai, et al.
Data in Brief|April 8, 2020
Differentiation of ripe and unripe fruit flour using mineral composition data-Statistical assessmentAbbas F M Alkarkhi, Wasin A A Alqaraghuli, N R Mohamed Zam, et al.
Blood|March 1, 1996
Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-betaK Ohishi, N Katayama, R Itoh, et al.
Blood|June 22, 2001
Highly abundant genes in the transcriptosome of human and baboon CD34 antigen-positive bone marrow cellsI Gomes, T T Sharma, N Mahmud, et al.
Leukemia & Lymphoma|March 14, 1998
Role for C-MPL and its ligand thrombopoietin in early hematopoiesisN Katayama, R Itoh, T Kato, et al.
Alimentary Pharmacology & Therapeutics|August 10, 2000
Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel diseaseY S Ang, N Mahmud, B White, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2001
A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia--are central serotoninergic responses enhanced?T G Dinan, N Mahmud, O Rathore, et al.
Leukemia & Lymphoma|May 9, 2001
Bcl-2 in cell-cycle regulation of hematopoietic cells by transforming growth factor-beta1N Katayama, N Mahmud, K Nishii, et al.
Bone Marrow Transplantation|February 12, 2008
Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?S Chunduri, L C Dobogai, D Peace, et al.
Gastroenterology|January 29, 2000
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapyR J Farrell, A Murphy, A Long, et al.
Pageof 7